Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Mouth Neoplasms 2Breast Neoplasms 2Tobacco Use Disorder 1Stomatitis 1Precancerous Conditions 1Neoplasms 1Multiple Myeloma 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Immunoglobulin Light-chain Amyloidosis 1Head and Neck Neoplasms 1Fanconi Anemia 1Erythroplasia 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Spectrometry, Fluorescence × Clear all
NCT00214292 2016-01-29

Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy

University of Wisconsin, Madison

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms

NCT00918216 2014-07-16

Spectroscopy of Breast Tissue

Case Comprehensive Cancer Center

Completed
141 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡